enzalutamide
Showing 376 - 394 of 394
CTCs and ctDNA in Blood and Plasma Samples From Metastatic
Terminated
- Hormone-Resistant Prostate Cancer
- Metastatic Prostate Carcinoma
- Cytology Specimen Collection Procedure
- Laboratory Biomarker Analysis
-
Los Angeles, CaliforniaUSC Norris Comprehensive Cancer Center
Apr 13, 2017
Prostate Cancer Trial in Chur, Basel, St.Gallen (abiraterone acetate)
Terminated
- Prostate Cancer
- abiraterone acetate
-
Chur, Graubuenden, Switzerland
- +2 more
Mar 22, 2017
Prostatic Tumors Trial in Rotterdam (cabazitaxel)
Withdrawn
- Prostatic Neoplasms
-
Rotterdam, NetherlandsErasmus MC Cancer Institute
Aug 16, 2016
Prostate Cancer, Castration-resistant Prostate Cancer Trial in Naples (Cabazitaxel, Prednisone)
Unknown status
- Prostate Cancer
- Castration-resistant Prostate Cancer
-
Naples, ItalyUniversity Federico II of Naples
Dec 13, 2017
Prostatic Tumors Trial in Trento (Docetaxel, Prednisone, Enzalutamide)
Unknown status
- Prostatic Neoplasms
- Docetaxel
- +2 more
-
Trento, ItalySanta Chiara Hospital
May 22, 2015
Prostate Cancer, Metastatic (Spread to Other Areas of the Body) Trial in Durham, Portland, Seattle (BKM120)
Terminated
- Prostate Cancer
- Metastatic (Spread to Other Areas of the Body)
-
Durham, North Carolina
- +2 more
Apr 14, 2017
Prostate Cancer, Localized Prostate Cancer Trial in Baltimore (Enzalutamide, Abiraterone acetate, Prednisone)
Withdrawn
- Prostate Cancer
- Localized Prostate Cancer
- Enzalutamide
- +4 more
-
Baltimore, MarylandJohns Hopkins Hospital
Jan 22, 2015
Atrial Fibrillation Trial in São Paulo (Marevan®, generic warfarin #1, generic warfarin #2)
Completed
- Atrial Fibrillation
- Marevan®
- +2 more
-
São Paulo, BrazilHospital São Paulo/Hospital Universitário da UNIFESP (University
Nov 21, 2016
Drug-Drug Interaction (DDI), Healthy Subjects, Pharmacokinetics of Enzalutamide Trial in Berlin (enzalutamide, rifampin)
Completed
- Drug-Drug Interaction (DDI)
- +2 more
- enzalutamide
- rifampin
-
Berlin, GermanyParexel International GmbH
Oct 14, 2014
Prostate Cancer, Pharmacokinetics of Enzalutamide Trial in United States (Enzalutamide tablet, Enzalutamide capsule)
Completed
- Prostate Cancer
- Pharmacokinetics of Enzalutamide
- Enzalutamide tablet
- Enzalutamide capsule
-
Denver, Colorado
- +3 more
Sep 8, 2014
Pharmacokinetics of MDV3100, Healthy Subjects, Kidney Diseases Trial in Chisinau (MDV3100)
Completed
- Pharmacokinetics of MDV3100
- +2 more
-
Chisinau, Moldova, Republic ofArensia
Sep 12, 2014
Severe Hepatic Impairment, Normal Hepatic Function Trial in Sofia (enzalutamide)
Completed
- Severe Hepatic Impairment
- Normal Hepatic Function
- enzalutamide
-
Sofia, BulgariaComac Medical Ltd.
May 12, 2014
Healthy Subjects, Pharmacokinetics of MDV3100 Trial in Zuidlaren (MDV3100)
Completed
- Healthy Subjects
- Pharmacokinetics of MDV3100
-
Zuidlaren, NetherlandsPRA International
Jul 26, 2013
Metastatic Castration-Resistant Prostate Cancer Trial (Enzalutamide)
Withdrawn
- Metastatic Castration-Resistant Prostate Cancer
- Enzalutamide
- (no location specified)
Sep 14, 2012